NasdaqGM - Nasdaq Real Time Price USD
XOMA Royalty Corporation (XOMA)
23.34
+0.19
+(0.82%)
At close: April 23 at 4:00:01 PM EDT
22.86
-0.48
(-2.06%)
Pre-Market: 4:29:04 AM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BURNS THOMAS M Chief Financial Officer | Sale | Nov 13, 2024 | 20,107 |
| BVF PARTNERS L P Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 24, 2025 | -- |
| HERNDAY NATASHA A Director | Stock Award(Grant) | May 15, 2024 | 3,035 |
| HUGHES OWEN Chief Executive Officer | Sale | Nov 13, 2024 | 34,979 |
| PERRY MATTHEW D Director | Stock Award(Grant) | May 15, 2024 | 17,869 |
| SITKO BRADLEY J. Chief Investment Officer | Purchase | Mar 31, 2025 | 13,963 |
| WYSZOMIERSKI JACK L Director | Stock Award(Grant) | May 15, 2024 | 12,533 |
Related Tickers
LGND Ligand Pharmaceuticals Incorporated
105.76
-0.67%
UBX Unity Biotechnology, Inc.
0.9860
+0.41%
CRIS Curis, Inc.
1.5000
+4.90%
DAWN Day One Biopharmaceuticals, Inc.
7.44
+1.50%
PHAR Pharming Group N.V.
8.27
+1.47%
AFMD Affimed N.V.
0.7703
+4.24%
JANX Janux Therapeutics, Inc.
31.62
+5.36%
GLYC GlycoMimetics, Inc.
0.2387
+4.69%
PTGX Protagonist Therapeutics, Inc.
46.16
+0.68%
BTAI BioXcel Therapeutics, Inc.
1.6900
+0.60%